Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Donald J. Ponec"'
Publikováno v:
Journal of Vascular and Interventional Radiology. 23:1302-1308
Purpose: This study proposed to prospectively evaluate safety and clinical changes in outpatient endovascular treatment in patients with multiple sclerosis (MS) and chronic cerebrospinal venous insufficiency (CCSVI). Materials and Methods: Two hundre
The Nitinol SMART Stent vs Wallstent for Suboptimal Iliac Artery Angioplasty: CRISP-US Trial Results
Autor:
Brian G. Firth, Michael R. Jaff, Jeffrey J. Popma, Munish Mehra, Donald J. Ponec, Dennis Donohoe, Emily Keim, James L. Swischuk, David Snead, John R. Laird, Andy Feiring
Publikováno v:
Journal of Vascular and Interventional Radiology. 15:911-918
PURPOSE The Cordis Randomized Iliac Stent Project–US (CRISP-US) trial evaluated, with an equivalence design, the performance of the shape memory alloy recoverable technology (SMART) nitinol self-expanding stent and the stainless steel Wallstent for
Publikováno v:
Journal of vascular and interventional radiology : JVIR. 18(11)
To assess the long-term patency of the Viabahn stent-graft after placement for the treatment of occlusive disease of the femoropopliteal artery (FPA).Viabahn stent-grafts were placed into 87 limbs in 76 patients for the treatment of atherosclerotic o
Publikováno v:
Techniques in vascular and interventional radiology. 7(1)
The results of infra-inguinal intervention for atherosclerotic occlusive disease have not changed dramatically in the last 15 years despite the advent of many different designs of uncovered stents. "Plain old balloon angioplasty" remains the treatmen
Publikováno v:
Journal of vascular and interventional radiology : JVIR. 14(3)
PURPOSE To describe a single-center experience as part of a U.S. multicenter prospective randomized trial of PTA versus percutaneous transluminal angioplasty (PTA)-and ePTFE (expanded polytetrafluoroethylene)-covered endoprosthesis placement for the
Autor:
Patricia A. Hill, Donald J. Ponec, David Irwin, Edward R. McCluskey, William D. Haire, Xin Li
Publikováno v:
Journal of vascular and interventional radiology : JVIR. 12(8)
Central venous access devices (CVADs) are a mainstay of current medical therapy but often become occluded by thrombus. Tissue plasminogen activator (alteplase), at a dose of 2 mg per 2 mL, has been shown to be effective in restoring flow to catheters